This is the authors' abstract. We don't add key points for this paper.
Eukaryotic elongation factor-2 kinase (eEF-2K), a member of the α−kinase family, modulates translational rates by phosphorylating eEF-2, a GTPase that facilitates the translocation of the nascent chain on the ribosome during the elongation phase of protein synthesis. eEF-2K is regulated by diverse cellular cues, many of which sensitize it to the Ca 2+ -effector protein calmodulin (CaM). CaM, which binds and allosterically activates eEF-2K in the presence of Ca 2+ , contains two structural “lobes,” each with a pair of Ca 2+ -binding EF-hands. Using kinetic analysis, we demonstrate that the isolated C-terminal lobe of CaM (CaM C ) is sufficient to engage and fully activate eEF-2K in a Ca 2+ -dependent fashion. Genetically fusing CaM C to the N-terminus of eEF-2K, upstream of its critical CaM-targeting motif (CTM) via a flexible 2-glycine linker, results in a chimeric species (C-LiNK) that is constitutively active independent of external CaM and Ca 2+ . A structure of the C-LiNK functional core reveals no significant deviation in the overall conformations of the interacting modules and orientations of key catalytic-site residues relative to the heterodimeric complex between full-length CaM and eEF-2K. These observations demonstrate that, in contrast to other CaM-regulated kinases, CaM C alone is sufficient to activate eEF-2K fully. The proximity effect of CaM C in the context of C-LiNK removes the requirement for external Ca 2+ , whose apparent role is to enhance the CaM-affinity of eEF-2K and drive kinase activation. The responsiveness of eEF-2K to regulatory stimuli in cells appears to be lost in C-LiNK, presumably due to its permanently “on” state.
No takes yet. Share an insight, caveat, or question.
Long et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: